Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first C11 – Lanreotide Autogel/Depot (LAN) Post-Octreotide Long-Acting Release (OCT) for Safe and Tolerable Treatment of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Published in 2016 Listed under Clinical, Poster Download Saif pdf Download Poster (669 KB) C11 – Neuroendocrine Tumors: A Review of the Sunnybrook Odette Cancer Centre Database Published in 2012 Listed under Clinical Download Jeffrey Craig; Simron Singh; Calvin Law; Matthew Cheung C11 – SDHB Pheochromocytoma and Paraganglioma Penetrance in a United States Population: An NIH Study Published in 2013 Listed under Clinical Download King C11 – The Prognostic Significance of Lymph Node Ratio in Carcinoid Tumors Published in 2014 Listed under Clinical Download Flatow C11 – Comparison of Hepatic Artery Embolization and Selective Internal Radiation Therapy for Metastatic Neuroendocrine Tumors Published in 2011 Listed under Clinical, Poster Download Eric S. Engelman, DO, Roberto Leon-Ferre, MD, Boris G. Naraev, MD, PhD, Nancy Sharma, MD, Shiliang Sun, MD, Thomas M. O'Dorisio, MD, Thorvardur R. Halfdanarson, MD pdf Download Poster (643 KB) C12 - Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms Published in 2019 Listed under Clinical Download Taymeyah Al-Toubah; Brian Morse; Jonathan Strosberg Abstract ID: 127 C12 - First in Human Phase 1/2a Study of PEN-221 Somatostatin Analog (SSA)-DM1 Conjugate for Patients (PTS) with Advanced Neuroendocrine Tumor (NET) or Small Cell Lung Cancer (SCLC): Phase 1 Results Published in 2018 Listed under Clinical, Poster Download Abstract ID: 106 Daniel M. Halperin, Melissa L. Johnson, Tim Meyer, Antonio Tito Fojo, Natalie Cook, Lawrence S. Blaszkowsky, Benjamin L. Schlechter, Jennifer Chan, James C Yao, Yannis Jemiai, Kristina Kriksciukaite, Laura Mei, Toyin Shonukan, Leila Alland, Richard Wooster, Matthew H. Kulke pdf Download Poster (2.58 MB) C12 – Dose-Escalation of Octreotide-LAR in Patients with Neuroendocrine Tumors (NET) Published in 2013 Listed under Clinical Download Kulke C12 – Multiple Endocrine Neoplasia (MEN1) Patients Need Close Monitoring and Aggressive Management Published in 2015 Listed under Clinical Download Christakis; Starker; Gilbert; Conrad; Katz; Qiu; Silva; Fellman; Graham; Grubbs; Yao; Lee; Perrier C12 – Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of DP1038, an Intranasal Formulation of Octreotide Acetate, in Healthy Volunteers Published in 2017 Listed under Clinical, Poster Download Lavisetti Abstract ID: 204 pdf Download Poster (758 KB) C12 – Response to Capecitabine and Temozolomide in an Adolescent Female with Metastatic, Non-functional Pancreatic Neuroendocrine Tumor Published in 2014 Listed under Clinical Download Gilbert C12 – Surgical Exploration is Superior to All Other Modalities for Locating Primary Carcinoid Tumors Published in 2010 Listed under Clinical, Poster Download Massimino Kristen P., Han Esther, Pommier SuEllen J., Pommier Rodney F pdf Download Poster (168 KB) C12 – The Clinical Utility of Ki-67 in Assessing Tumor Biology and Aggressiveness in Patients with Appendiceal Carcinoids Published in 2009 Listed under Clinical, Poster Download Eric Liu, MD, Dana A. Telem, MD, John Hwang, BA, Richard R. P. Warner, MD, Steven H. Dikman, MD, and Celia M. Divino, MD, FACS Department of Surgery, Department of Internal Medicine, Section of Gastroenterology, and Department of Pathology, Mount Sinai School of Medicine, New York, NY pdf Download Poster (83 KB) C12 – The Risk of Adenocarcinoma of the Stomach in Type I Carcinoid Published in 2012 Listed under Clinical, Poster Download Michelle Cramblitt, RN; Matthew M. Eves, MD, FACG pdf Download Poster (223 KB) C12 – Use of Alklyating Chemotherapy in High Grade Neuroendocrine Tumours: Evaluation of Real World Data Published in 2016 Listed under Clinical Download Sathiyapalan C12 – Analysis of Progression-Free Survival (PFS) by Prior Chemotherapy Use and Updated Safety in RADIANT-3: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial of Everolimus in Patients with Advanced Low- or Intermediate-Grade Pa Published in 2011 Listed under Clinical, Poster Download Timothy Hobday, Rodney Pommier, Eric Van Cutsem, Ashok Panneerselvam, Stephen Saletan, Robert E. Winkler, James C. Yao pdf Download Poster (339 KB) C13 - Integrating a Paradigm Shift in the Treatment of Neuroendocrine Tumors and Carcinoid Syndrome: Effect of Online CME on Clinicians Knowledge and Competence Published in 2018 Listed under Clinical Download Abstract ID: 56 Tara Herrmann, Davecia Cameron, Emily Van Laar C13 - Tumor Growth Rate (TGR) to Monitor Growth/Predict Response to Lanreotide Autogel Use Before, During and After PRRT in Advanced GEP-NETS: Data from the PRELUDE Study Published in 2019 Listed under Clinical Download Lisa Bodei; Raj Srirajaskanthan; Chiara Maria Grana; Sergio Baldari; Tahir Shah; Angela Lamarca; Frédéric Courbon; Klemens Scheidhauer; Eric Baudin; Gustave Roussy Xuan-Mai; Truong Thanh; Aude Houchard; Vikas Prasad Abstract ID: 144 C13 – Everolimus for Advanced, Progressive, Nonfunctional Neuroendocrine Tumors (NET) of the Gastrointestinal (GI) Tract: Efficacy and Safety from a RADIANT-4 Subgroup Analysis Published in 2016 Listed under Clinical Download Singh C13 – Extensive Retroperitoneal Carcinoid Involving the Mesenteric Vasculature Does Not Preclude Effective Cytoreduction Published in 2009 Listed under Clinical Download John M. Lyons, III, Erica Lindholm, Yi-Zarn Wang, Jessica L. Thomson, Lowell B. Anthony, Eugene A. Woltering, Daniel J. Frey, Saju Joseph, Thiagaran Ramacharan and J. Philip Boudreaux C13 – Identification of Response Predictors to Capecitabine/ Temozolommide in Metastatic Pancreatic Neuroendocrine Tumors Published in 2015 Listed under Clinical Download Cives; Ghayouri; Brelsford; Black; Rizzo; Meeker; Strosberg C13 – Patient-Reported Symptom Experiences Following Participation in a Study of Telotristat Etiprate for Patients with Carcinoid Tumor and Octreotide-Refractory Diarrhea Published in 2013 Listed under Clinical Download Kulke C13 – Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTA Octreotate for Somatostatin Receptor-expressing Neuroendocrine Tumors: The First U.S. Experience Published in 2012 Listed under Clinical, Poster Download Ebrahim S. Delpassand; Amin Samarghandi; Sara Zamanian; Jack Erion; Jim Somone; Robert Wolfangel; Edward M. Wolin; Gregory D. Espenan pdf Download Poster (306 KB) C13 – Small Cell Carcinoma of the Uterine Cervix: A Single-Center Experience Published in 2010 Listed under Clinical, Poster Download Boris G. Naraev, MD, PhD, Michael J. Goodheart, MD, Thomas M. O’Dorisio, MD, Thorvardur R. Halfdanarson, MD pdf Download Poster (620 KB) C13 – Small Intestine Neuroendocrine Tumors: Frequently of Unrecognized Primary Site and Multifocal Published in 2014 Listed under Clinical Download Javeed C13 – Use of Somatostatin Analog Therapy in Patients with Advanced Pheochromocytoma/Paraganglioma and Somatostatin-Receptor Avid Disease Published in 2017 Listed under Clinical, Poster Download Narayan Abstract ID: 228 pdf (727 KB) pdf Download Poster (1.64 MB) C13 – Hepatic Artery Radioembolization (HARE) in the Management of Progressive Metastatic Neuroendocrine Tumors (NETs): A Survival and Biochemical Response Analysis in Geriatric (G) and Young (Y) Populations Published in 2011 Listed under Clinical, Poster Download Khawaja Saad Jahangir, MD, Ryan Majoria, MD, Joe Hagan, PhD, Philip Boudreaux, MD, Yi-Zarn Wang, MD, Brian Boulmay, MD, Richard Campeau, MD, Eugene Woltering, MD, Lowell Anthony, MD pdf Download Poster (2.92 MB) C14 - Improvement in Carcinoid Syndrome- Related Symptoms with Telotristat Ethyl in Patients with 2 or Less Bowel Movements Per Day Published in 2019 Listed under Clinical Download Valentina Di Gialleonardo; Eshetu Tesfaye; Ashwin Kittur; Susan Giacalone; Pablo Lapuerta Abstract ID: 145 C14 - Multicenter Phase 2 Study of Nintedanib in Patients (pts) with Advanced Progressing Carcinoid Tumors Published in 2018 Listed under Clinical, Poster Download Abstract ID: 39 Renuka Iyer, Bhavana Konda, Dwight Owen, Kristopher Attwood, Suman Sarker, Sheryl-Ann Suffren, John Wilton, Robert Bies, Diane Reidy-Lagunes, Manisha Shah pdf Download Poster (1.70 MB) C14 – A Population Based Pathology Analysis on Application of WHO- Nomenclature in Pulmonary Neuroendocrine Tumors Published in 2015 Listed under Clinical, Poster Download Derks; Jan van Suylen; Thunnissen; Bakker; Smit; Groen; Speel; Dingemans pdf Download Poster (797 KB) C14 – Comparison of 68Ga-DOTATATE (Ga) PET/CT with 111In-Octreotide (Octreoscan) SPECT in Somatastatin Positive Neuroendocrine Tumors (NET) Published in 2013 Listed under Clinical Download Kumar C14 – Elevated Serum Pancreastatin is an Indicator of Hepatic Metastasis in Patients with Small Bowel Neuroendocrine Tumors Published in 2014 Listed under Clinical Download Khan C14 – Evaluation of Chromogranin A and Neuron-specific Enolase as Predictors of Response to Everolimus Therapy in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) Published in 2010 Listed under Clinical, Poster Download Kjell Öberg, Matthew Kulke, Marianne Pavel, Alexandria Phan, Sakina Hoosen, Jessica St. Peter, Azzeddine Cherfi, and James C. Yao pdf Download Poster (272 KB) C14 – Gluteal Intramuscular Injections: CT Evaluation of Factors Associated with Success and Failure Published in 2009 Listed under Clinical Download Jeannette E. Mares, Cecile G. Dagohoy, Colleen C. Leary, Linda L. DeFord, Valentine G. Boving, James P. Brook, Jeana L. Garris, April E. Boyd, Alexandria T. Phan, James C. Yao C14 – Management of Breast Metastases from Gastroenteropancreatic Neuroendocrine Tumor Origin Published in 2012 Listed under Clinical, Poster Download Jeremiah L. Deneve, DO; Larry Kvols, MD; Marilyn M. Bui, MD; Jonathan R. Strosberg, MD; John V. Kiluk, MD; Christine Laronga, MD; Marie C. Lee, MD; Nazanin Khakpour, MD pdf Download Poster (1.04 MB) C14 – Phase I, Multi-center, Open-label, Dose-escalation Study of Pasireotide LAR (PAS) in Patients With Advanced Neuroendocrine Tumors (NET) Published in 2016 Listed under Clinical Download Strosberg C14 – Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial Published in 2017 Listed under Clinical, Poster Download Pavel Abstract ID: 213 pdf Download Poster (727 KB) C14 – Efficacy of Telotristat Etiprate in Refractory Carcinoid Syndrome: Preliminary Results of a Randomized, Placebo-Controlled, Multicenter Study Published in 2011 Listed under Clinical, Poster Download Matthew H. Kulke, Thomas O'Dorisio, Alexandria Phan, Robert Langdon Jr, Billie Marek, Nadeem Ikhlaque, Emily Bergsland, Joel Freiman, Linda Law, Phillip Banks, Kenny Frazier, Jessica Jackson, Brian Zambrowicz pdf Download Poster (141 KB) C15 - Study on the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors: Traditional Chinese Medicine Combined with Somatostatin Analogues Published in 2019 Listed under Clinical Download Xudong Qiu; Zhirong Qi; Yuanliang Li; Huangying Tan Abstract ID: 146 C15 - XERMELO Patient Registry: A Real-World Evidence Study Evaluating Patient Reported Outcomes with XERMELO Published in 2018 Listed under Clinical, Poster Download Abstract ID: 28 Vijay N. Joish, Mark A. Price, Steven Schwartz, Shanna Stanley, Lee Bennett, Christina Darden, Eshetu Tesfaye, Quintella Mobley, Karie Arnold, Suman Wason, Pablo Lapuerta pdf Download Poster (1.10 MB) C15 – A Multi-Gene Transcript Blood Molecular Signature for Gut Neuroendocrine Tumors (NETs) Delineates Surgical Efficacy Published in 2014 Listed under Clinical Download Kidd C15 – A Single Fasting Plasma 5-HIAA Value Correlates with 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs) Published in 2012 Listed under Clinical, Poster Download Anne E. Diebold BS; Maria R. Tellez PhD; Gregg Mamikunian, MS; Vay Liang W. Go, MD; Thomas M. O’Dorisio, MD; Aaron I. Vinik, MD PhD; Eugene A. Woltering, MD pdf Download Poster (229 KB) C15 – Clinical Features of Large Cell Neuroendocrine Carcinoma: A Population Based Overview Published in 2015 Listed under Clinical, Poster Download Derks; Hendricks; Buikhuisen; Groen; Thunnissen; Jan van Suylen; Houben; Damhuis; Speel; Dingemans pdf Download Poster (1.48 MB) C15 – Is Patient Age Associated with Improved Survival after Transarterial Chemoembolization (TACE) for Unresectable Neuroendocrine Tumor (NET) Metastasis? Published in 2009 Listed under Clinical Download Ruhina Mehra, Kevin Tri Nguyen MD, PhD, Jennifer Steel PhD, Nikhil Amesur MD, Richard Raizman MD, Scott Celinski MD, Allan Tsung MD, T. Clark Gamblin MD, MS C15 – Long-term Safety/Tolerability of Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumors (NETs) Patients with Carcinoid Syndrome (CS): The ELECT Long-term Open-label Extension Published in 2016 Listed under Clinical, Poster Download Vinik pdf Download Poster (828 KB) C15 – Patterns of Hepatic Metastases in Midgut Carcinoid: Diffuse Micrometastases and Disease Recurrence Published in 2013 Listed under Clinical Download Liu C15 – Predictors of Lymph Node Sampling and Nodal Metastases in Patients with Pancreatic Neuroendocrine Tumors Published in 2010 Listed under Clinical Download Justin Parekh, MD, Sam C. Wang, MD, Emily K. Bergsland, MD, Alan P. Venook, MD, Robert S. Warren, MD, Grace E. Kim, MD, Eric K. Nakaura, MD, PhD, These authors contributed equally to this work C15 – Safety and Tolerability of Lanreotide Autogel/Depot in Patients with Neuroendocrine Tumors: Pooled Analysis of Clinical Studies Published in 2017 Listed under Clinical Download Phan Abstract ID: 226 C15 – Resection of At-Risk Mesenteric Lymph Nodes Improves the Outcome of Patients with Small Bowel Neuroendocrine Tumors Published in 2011 Listed under Clinical, Poster Download Christine S. Landry MD, Heather Y. Lin PhD, Alexandria Phan MD, Chusilp Charnsangavej MD, Eddie K. Abdalla MD, J. Nicolas Vauthey MD, James C. Yao MD, Jason B. Fleming MD pdf Download Poster (315 KB) C16 - Clinical Efficacy and Toxicity Data on Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors Published in 2019 Listed under Clinical Download Aman Chauhan; Susanne Arnold; John Wu; Rashmi Nair; Stacey Slone; Emily Dressler; Heather Flynn; Val Adams; Heidi Weiss; Mark Evers; Lowell Anthony Abstract ID: 153 C16 - Real-world Analysis of Long-Term Treatment Patterns in Patients with Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Study Published in 2018 Listed under Clinical, Poster Download Abstract ID: 25 Matthew Helmet Kulke, Al B Benson, Arvind Dasari, Lynn Huynh, Beilei Cai, Todor Totev, Nina Roesner, Mei Sheng Duh, Maureen P Neary, Emily K Bergsland pdf Download Poster (610 KB) C16 – Cisplatin plus Etoposide in the Management of Metastatic Neuroendocrine Tumors of the Colon and Rectum Published in 2010 Listed under Clinical, Poster Download Patta Annie and Fakih Marwan.G pdf Download Poster (260 KB) C16 – Development and Preclinical Evaluation of the New Pan-Somatostatin PET Imaging Probe 68Ga-DOTA-SOM230 (SOMscan®) Published in 2012 Listed under Clinical, Poster Download Melpomeni Fani; Eleni Gourni; Friederike Braun; Anika Mann;rea Kliewer; Jens Kaufmann; Angela Dreykluft; Wolfgang A. Weber; Hakim Bouterfa; Stefan Schulz; Helmut R. Maecke pdf Download Poster (837 KB) C16 – Elevated Levels of 5-HIAA and CgA in Patients with Pancreatic Neuroendocrine Tumors (PanNETs): Analyses from the CLARINET Study Published in 2017 Listed under Clinical Download Phan Abstract ID: 226 C16 – Everolimus (EVE) in Advanced, Nonfunctional, Well-differentiated Neuroendocrine Tumors (NET) of Gastrointestinal (GI) or Lung Origin: Second Interim Overall Survival (OS) Results From the RADIANT-4 Study Published in 2016 Listed under Clinical Download Yao C16 – Identification of Unknown Primary Tumors in Patients with Neuroendocrine Liver Metastases Published in 2009 Listed under Clinical Download Sam C. Wang, Justin R. Parekh, Marlene B. Zuraek, Alan P. Venook, Emily K. Bergsland, Robert S. Warren, Eric K. Nakakura C16 – Neuroendocrine Tumors Arising in Meckel's Diverticula: Frequency of Advanced Disease Warrants Aggressive Management Published in 2013 Listed under Clinical Download Lorenzen C16 – Prognostic Significance of the Extent of Lymph Node Metastases in Small Intestinal Neuroendocrine Tumors Published in 2014 Listed under Clinical Download Kim C16 – Treatment Patterns and Outcomes in Metastatic Neuroendocrine Tumors: Results From a Retrospective Community Oncology Database Published in 2015 Listed under Clinical, Poster Download Fisher; Pulgar; Kulke; Lowenthal; Cox; Miller; Walker; Schwartzberg pdf Download Poster (755 KB) C16 – Single Dose Prophylactic Octreotide Does Not Prevent Intraoperative Carcinoid Crisis Published in 2011 Listed under Clinical Download Kristen P. Massimino, Ola Harrskog, SuEllen J. Pommier, Rodney F. Pommier C17 - A Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors: A Trial of the ECOG-ACRIN Cancer Research Group (E2211) Published in 2018 Listed under Clinical Download Abstract ID: 50 Pamela L. Kunz, Paul Catalano, Halla S. Nimeiri, George A. Fisher, Jr., Teri A. Longacre, Carlos J. Suarez, James C. Yao, Matthew H. Kulke, Andrew Hendifar, James C. Shanks, Manisha H. Shah, Mark M. Zalupski, Edmond Schmulbach, Diane L. Reidy-Lagunes, Jonathan R. Strosberg, Peter J. O’Dwyer, Al B. Benson C17 - Enhancing Patient Care via Co-Creation and Validation of a New and Improved Delivery System for Lanreotide Autogel/Depot: Focus on its Evaluation by US Healthcare Professionals Published in 2019 Listed under Clinical Download Daphne Adelman; Xuan-Mai Truong Thanh; Clémentine Megret Abstract ID: 156 C17 – 5-Fluorouracile/Capecitabine and Oxaliplatin (FOLFOX/XELOX) Suitable Treatments for Progressing G1-G2 Neuroendocrine Tumors Published in 2013 Listed under Clinical Download Marconcini C17 – A phase II clinical trial of MK-0646, an insulin-like growth factor-1 receptor inhibitor (IGF-1R) in patients with metastatic well differentiated neuroendocrine tumors (NETs) Published in 2010 Listed under Clinical, Poster Download D. L. Reidy, E. Hollywood, M. Segal, L. Saltz pdf Download Poster (79 KB) C17 – Comparison of the Effectiveness of 68Ga-DOTATATE PET/CT and 111In-Octreotide SPECT in Patients with Somatostatin Positive Neuroendocrine Tumor Published in 2014 Listed under Clinical Download Kumar C17 – Efficacy and Safety of Lanreotide Depot vs Placebo in Patients With Neuroendocrine Tumor and a History of Carcinoid Syndrome and Prior Octreotide Therapy Published in 2015 Listed under Clinical Download Fisher, Jr; Wollin; Kunz; Liyanage; Gomez-Panzani; Lowenthal; Pommier C17 – Expert Panel Consensus Statements on the Medical Treatment of Unresectable Pancreatic Neuroendocrine Tumors Published in 2012 Listed under Clinical, Poster Download George A. Fisher; Jonathan R. Strosberg; Al B. Benson; Jennifer L. Malin; Lowell B. Anthony; Bulent Arslan; John F. Gibbs; Edward Greeno; Renuka V. Iyer; Michelle K. Kim; William J. Maples ; Philip. A. Philip; Edward M. Wolin; Dasha Cherepanov; Michael S. Broder pdf Download Poster (285 KB) C17 – Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Patients With Neuroendocrine Tumors (NETs) Previously Responsive to Octreotide: Subanalysis of Patient-Reported Symptoms From the Phase 3 ELECT Study Published in 2017 Listed under Clinical Download Pommier Abstract ID: 223 C17 – Pitfalls in the Response Evaluation after Peptide Receptor Radionuclide Therapy with [177Lu-DOTA0,Tyr3]Octreotate Published in 2016 Listed under Clinical Download Brabander C17 – RUNX1T1: A Novel Predictor of Liver Metastasis in Primary Pancreatic Published in 2009 Listed under Clinical Download Aejaz Nasir, James Helm, Leslie M. Turner, Evita B Henderson-Jackson, Jonathan R. Strosberg, Nelly A. Nasir, Ardeshir Hakam, Domenico Coppola, Larry K. Kvols C17 – Reproducibility of [68Ga]DOTATOC Imaging in Neuroendocrine Tumors Published in 2011 Listed under Clinical Download Yusuf Menda, MD, Laura L. Boles Ponto, PhD, Thomas O'Dorisio, MD, Michael K. Schultz, PhD, G. Leonard Watkins, PhD, John Sunderland, PhD, Michael Graham, MD PhD, David Bushnell, MD, M. Sue O'Dorisio, MD, PhD C18 - Antitumor Efficacy of Concurrent Everolimus with Hepatic Transarterial Bland Embolization (Evero-Embo) in Patients with Metastatic Well Differentiated Neuroendocrine Tumor (NET) Published in 2019 Listed under Clinical Download Lowell Anthony; Gaby Gabriel; Riham El Khouli; Aman Chauhan Abstract ID: 164 C18 - Outcomes with 5-Fluorouracil, Doxorubicin and Streptozocin (FAS) and Subsequent Therapies in Patients with Well Differentiated Pancreatic Neuroendocrine Tumors (PanNETs) Published in 2018 Listed under Clinical, Poster Download Abstract ID: 77 Michael Lam, Jane Rogers, Daniel Halperin, Cecile Dagohoy, James Yao, Arvind Dasari pdf Download Poster (467 KB) C18 – A Phase I/II Study of TKM- 080301, a RNAi Theraputic Directed Against Polo- Like Phase Kinase 1 (PLK1), in Patients with Gastrointestinal Neuroendocrine Tumors (GI-NET) Published in 2015 Listed under Clinical Download Halfdanarson; Armaghany; Ejadi; Northfelt; Ramanathan; Strosberg; Smith; Vaena; Fredlund; Semple; Gahir; Dye; Kowalski C18 – DNA-repair Defects in Pancreatic Neuroendocrine Tumors and Potential Clinical Applications Published in 2014 Listed under Clinical Download Liu C18 – KI-67 Heterogeneity in Gastro-Entero-Pancreatic Neuroendocrine Tumors Published in 2012 Listed under Clinical, Poster Download Federicca Grillo; Manuela Albertelli; Paola Calamaro; Borra Tiziana; Sara Bruno; Luca Mastracci; Roberto Fiocca; Diego Ferone pdf Download Poster (730 KB) C18 – Long-term Efficacy, Survival and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors Published in 2016 Listed under Clinical Download Brabander C18 – Neuroendocrine Tumors Treated with Lanreotide After First Line Treatment with Octreotide LAR: A Single Center Experience Published in 2013 Listed under Clinical Download Marconcini C18 – Pharmacist-Led Development of an Adverse Event (AE) Management Algorithm for the Proactive Monitoring of Patients with Neuroendocrine Tumours (NETs) on Everolimus Published in 2017 Listed under Clinical Download Thawer Abstract ID: 299 C18 – Primary Gastro-entero-pancreatic Poorly Differentiated Neuroendocrine Carcinoma: Clinico-pathologic and Survival Analysis in 68 Cases Published in 2009 Listed under Clinical Download Aejaz Nasir, Mulazim H. Bukhari, Elizabeth Byron, Jonathan R. Strosberg, Evita B. Henderson-Jackson, Domenico Coppola, Larry K. Kvols C18 – The Addition of Octreotide Functional Imaging to CT or MRI Cross-Sectional Imaging for the Detection of Neuroendocrine Tumors (NETs) - Added Value or an Anachronism? Published in 2010 Listed under Clinical, Poster Download Diane L Reidy, Marc J Gollub, and Leonard B Saltz pdf Download Poster (80 KB) C18 – High Grade Neuroendocrine Carcinoma of the Uterine Cervix: Outcomes and the Role of Radiation and Chemotherapy -- The University of Iowa Experience Published in 2011 Listed under Clinical, Poster Download Boris G. Naraev, MD, PhD, Nancy Sharma, MD, Michael J. Goodheart, MD, Thomas M. O'Dorisio, MD, Thorvardur R. Halfdanarson, MD pdf Download Poster (336 KB) C19 - TACE or TARE? Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor Published in 2019 Listed under Clinical Download Brian Currie; Gregory Nadolski; Jeffrey Mondschein; Mandeep Dagli; Deepak Sudheendra; S. William Stavropoulos; Michael Soulen Abstract ID: 16 C19 - The Modified Subtype Classification for Gastric Neuroendocrine Neoplasms Published in 2018 Listed under Clinical, Poster Download Abstract ID: 66 Yuanliang Li, Pan Zhang, Yu Zhang, Xiaokou Li, Zhiwei Zhou, Wei Wang, Cheng Fang, Fei Yin, Hong Zhao, Xiao Chen, Jie Li, PanPan Zhang, Ye Chen, Huishan Chen, Jianming Xu, Xianjun Yu, Runxiang Yang, Jie Luo, Jie Chen, Huangying Tan pdf Download Poster (622 KB) C19 – Long-term Efficacy, Survival and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors Published in 2016 Listed under Clinical Download Brabander C19 – Long-term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Liver Metastases Published in 2014 Listed under Clinical Download Partelli C19 – Mitotic index and somatostatin receptor status are independent predictors of survival after resection of neuroendocrine tumors metastatic to the liver Published in 2010 Listed under Clinical Download Sasan Roayaie, Paramjeet Singh, Hongfa Zhu, Lihui Qin, Daniel Labow, Michelle Kim, Richard R. P. Warner, Myron Schwartz C19 – Multi-center Phase II Trial of Temsirolimus (TEM) and Bevacizumab (BEV) in Pancreatic Neuroendocrine Tumor (PNET): Results of a Planned Interim Efficacy Analysis Published in 2012 Listed under Clinical, Poster Download Timothy Hobday MD; Rui Qin PhD; Diane Reidy MD; Malcolm Moore MD; Jonathan Strosberg MD;reas Kaubisch MD; Manisha Shah MD; Hedy Kindler MD; Heinz-Joseph Lenz MD; Helen Chen MD; Charles Erlichman MD pdf Download Poster (632 KB) C19 – Neuroendocrine Tumors in Children and Young Adults: Incidence, Survival, and Prevalence in the United States Published in 2009 Listed under Clinical, Poster Download P. Navalkele, M. O'Dorisio, T. M. O'Dorisio, C. F. Lynch pdf Download Poster (677 KB) C19 – Real-World Treatment Patterns in Advanced Pancreatic Neuroendocrine Tumors in the Era of Targeted Therapy: Perspectives from an Academic Tertiary Center and Community Oncology Practices Published in 2015 Listed under Clinical Download Herring; Huynh; Duh; Vekeman; Tiew; Neary; Bergsland C19 – Recurrence After Complete Resection of Gastrointestinal (GNET) or Pancreatic Neuroendocrine Tumors (PNET): Single Center Analysis Published in 2013 Listed under Clinical Download Marconcini C19 – Weight Change Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome Published in 2017 Listed under Clinical, Poster Download Weickert Abstract ID: 253 pdf Download Poster (727 KB) C19 – Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Low Grade Neuroendocrine Tumors (mNETs) Published in 2011 Listed under Clinical, Poster Download Boris G. Naraev MD, PhD, Nancy Sharma, MD, Eric S. Engelman, DO, David L. Bushnell, Jr., MD, Thomas M. O'Dorisio, MD, Thorvardur R. Halfdanarson, MD pdf Download Poster (645 KB) C2 - Netazepide, a Gastrin/CCK2 ‚ Receptor Antagonist, Can Eradicate Gastric Neuroendocrine Tumours in Patients with Autoimmune Chronic Atrophic Gastritis Published in 2018 Listed under Clinical, Poster Download Abstract ID: 31 Malcolm Boyce, Andrew R Moore, Bryony Parsons, Katie Lloyd, Liv Sagatun, Andrea Varro, Reidar Fossmark, Helge Waldum, D Mark Pritchard pdf Download Poster (714 KB) C2 - Real-World Comparison of Lanreotide and Octreotide LAR Use for Neuroendocrine Tumours (NETs) in British Columbia, Canada Published in 2019 Listed under Clinical Download Shehara Mendis; Justin Jao; M.K.C. Lee; Sharlene Gill; David Schaeffer; Daniel Renouf; Jonathan Loree Abstract ID: 50 C20 - 64Cu-DOTATATE Somatostatin Receptor Imaging in Neuroendocrine Tumor Patients: Experience from More Than 600 Patients Published in 2019 Listed under Clinical Download Andreas Kjaer; Tina Binderup; Camilla Johnbeck; Esben Carlsen; Mathias Loft; Seppo Langer; Birgitte Federspiel; Ulrich Knigge Abstract ID: 25 C20 - Efficacy of 2nd-line Chemotherapy in Patients with Poorly Differentiated, High Grade Extrapulmonary Neuroendocrine Carcinoma (PD NEC) Published in 2018 Listed under Clinical, Poster Download Abstract ID: 23 Patrick McGarrah, Konstantinos Leventakos, Gustavo Westin, Heidi Finnes, Julian Molina, Timothy Hobday, Thorvardur Halfdanarson pdf Download Poster (244 KB) C20 – A Prospective, Multi-Institutional Phase II Study of Pazopanib and Depot Octreotide in Advanced, Well-Differentiated Neuroendocrine Tumors Published in 2014 Listed under Clinical Download Phan C20 – Bone Metastases in Well-to-Moderately Differentiated Neuroendocrine Tumors: A Review of Clinical Characteristics, Hormone Levels, and Survival Published in 2012 Listed under Clinical, Poster Download Juraj Kavecansky, MD; Lai Wei; Lisa Caronia; Mark Bloomston, MD; Manisha Shah, MD pdf Download Poster (4.62 MB) C20 – Extensive “Multitasking” Surgery for Advanced Enteropancreatic Neuroendocrine Tumors (NETS): A Safe and Effective Approach Published in 2010 Listed under Clinical, Poster Download Michail Shafir MD, Richard PR Warner MD, Sheilah Gonsalves MD, Jerome J Zacks, MD, Lynn Ratner MD, Michelle Kim MD pdf Download Poster (4.11 MB) Select the number of documents per page 5 10 15 20 25 30 50 100 «1234…67»
